Literature DB >> 33521759

Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China.

Ran Wu1, Siqi Ai2, Jing Cai1, Shiyu Zhang2, Zhengmin Min Qian3, Yunquan Zhang4, Yinglin Wu2, Lan Chen2, Fei Tian2, Huan Li2, Mingyan Li1, Hualiang Lin2.   

Abstract

An increasing number of patients are being killed by coronavirus disease 2019 (COVID-19), however, risk factors for the fatality of COVID-19 remain unclear. A total of 21,392 COVID-19 cases were recruited in the Hubei Province of China between December 2019 and February 2020, and followed up until March 18, 2020. We adopted Cox regression models to investigate the risk factors for case fatality and predicted the death probability under specific combinations of key predictors. Among the 21,392 patients, 1,020 (4.77%) died of COVID-19. Multivariable analyses showed that factors, including age (≥60 versus <45 years, hazard ratio [HR] = 7.32; 95% confidence interval [CI], 5.42, 9.89), sex (male versus female, HR = 1.31; 95% CI, 1.15, 1.50), severity of the disease (critical versus mild, HR = 39.98; 95% CI, 29.52, 48.86), comorbidity (HR = 1.40; 95% CI, 1.23, 1.60), highest body temperature (>39°C versus <39°C, HR = 1.28; 95% CI, 1.09, 1.49), white blood cell counts (>10 × 109/L versus (4-10) × 109/L, HR = 1.69; 95% CI, 1.35, 2.13), and lymphocyte counts (<0.8 × 109/L versus (0.8-4) × 109/L, HR = 1.26; 95% CI, 1.06, 1.50) were significantly associated with case fatality of COVID-19 patients. Individuals of an older age, who were male, with comorbidities, and had a critical illness had the highest death probability, with 21%, 36%, 46%, and 54% within 1-4 weeks after the symptom onset. Risk factors, including demographic characteristics, clinical symptoms, and laboratory factors were confirmed to be important determinants of fatality of COVID-19. Our predictive model can provide scientific evidence for a more rational, evidence-driven allocation of scarce medical resources to reduce the fatality of COVID-19.
© 2020 The Author(s).

Entities:  

Keywords:  COVID-19; fatality; risk factor

Year:  2020        PMID: 33521759      PMCID: PMC7832941          DOI: 10.1016/j.xinn.2020.100022

Source DB:  PubMed          Journal:  Innovation (N Y)        ISSN: 2666-6758


  28 in total

1.  Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.

Authors:  Hao Li; Zhenfan Wang; Fan Yang; Jun Wang
Journal:  J Surg Oncol       Date:  2020-02-05       Impact factor: 3.454

2.  Care for Critically Ill Patients With COVID-19.

Authors:  Srinivas Murthy; Charles D Gomersall; Robert A Fowler
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

3.  Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.

Authors:  Lin-Quan Tang; Chao-Feng Li; Jing Li; Wen-Hui Chen; Qiu-Yan Chen; Lian-Xiong Yuan; Xiao-Ping Lai; Yun He; Yun-Xiu-Xiu Xu; Dong-Peng Hu; Shi-Hua Wen; Yu-Tuan Peng; Lu Zhang; Shan-Shan Guo; Li-Ting Liu; Ling Guo; Yi-Shan Wu; Dong-Hua Luo; Pei-Yu Huang; Hao-Yuan Mo; Yan-Qun Xiang; Rui Sun; Ming-Yuan Chen; Yi-Jun Hua; Xing Lv; Lin Wang; Chong Zhao; Ka-Jia Cao; Chao-Nan Qian; Xiang Guo; Yi-Xin Zeng; Hai-Qiang Mai; Mu-Sheng Zeng
Journal:  J Natl Cancer Inst       Date:  2015-10-14       Impact factor: 13.506

4.  Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong.

Authors:  Kin Wing Choi; Tai Nin Chau; Owen Tsang; Eugene Tso; Ming Chee Chiu; Wing Lok Tong; Po Oi Lee; Tak Keung Ng; Wai Fu Ng; Kam Cheong Lee; William Lam; Wai Cho Yu; Jak Yiu Lai; Sik To Lai
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

5.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.

Authors:  Yizhou Wang; Jun Li; Yong Xia; Renyan Gong; Kui Wang; Zhenlin Yan; Xuying Wan; Guanghua Liu; Dong Wu; Lehua Shi; Wanyee Lau; Mengchao Wu; Feng Shen
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

Review 6.  Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.

Authors:  Jia Liu; Xin Zheng; Qiaoxia Tong; Wei Li; Baoju Wang; Kathrin Sutter; Mirko Trilling; Mengji Lu; Ulf Dittmer; Dongliang Yang
Journal:  J Med Virol       Date:  2020-02-21       Impact factor: 2.327

7.  Urgent need of a management plan for survivors of COVID-19.

Authors:  Bartolome Celli; Leonardo M Fabbri
Journal:  Eur Respir J       Date:  2020-04-23       Impact factor: 16.671

Review 8.  SARS and MERS: recent insights into emerging coronaviruses.

Authors:  Emmie de Wit; Neeltje van Doremalen; Darryl Falzarano; Vincent J Munster
Journal:  Nat Rev Microbiol       Date:  2016-06-27       Impact factor: 60.633

9.  Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease.

Authors:  Jong Hyun Jhee; Young Su Joo; Jung Tak Park; Tae-Hyun Yoo; Sue Kyung Park; Ji Yong Jung; Soo Wan Kim; Yun Kyu Oh; Kook-Hwan Oh; Shin-Wook Kang; Kyu Hun Choi; Curie Ahn; Seung Hyeok Han
Journal:  Kidney Res Clin Pract       Date:  2020-03-31

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  6 in total

1.  Implementing Silica Nanoparticles in the Study of the Airborne Transmission of SARS-CoV-2.

Authors:  Robert Hildebrandt; Krystian Skubacz; Izabela Chmielewska; Zdzisław Dyduch; Aleksandra Zgórska; Adam Smoliński
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

2.  An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital.

Authors:  Hazal Cansu Acar; Günay Can; Rıdvan Karaali; Şermin Börekçi; İlker İnanç Balkan; Bilun Gemicioğlu; Dildar Konukoğlu; Ethem Erginöz; Mehmet Sarper Erdoğan; Fehmi Tabak
Journal:  BMC Infect Dis       Date:  2021-02-05       Impact factor: 3.090

3.  Improvements throughout the Three Waves of COVID-19 Pandemic: Results from 4 Million Inhabitants of North-West Italy.

Authors:  Valeria Caramello; Alberto Catalano; Alessandra Macciotta; Lucia Dansero; Carlotta Sacerdote; Giuseppe Costa; Franco Aprà; Aldo Tua; Adriana Boccuzzi; Fulvio Ricceri
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

4.  Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional Study.

Authors:  Moran Dong; Zuyao Yang; Yingyao Chen; Jiufeng Sun; Wenjun Ma; Shouzhen Cheng; Xiaoli Sun; Jianpeng Xiao; Guanhao He; Jianxiong Hu; Jiaqi Wang; Guimin Chen; He Zhou; Lixia Yuan; Jiali Li; Xuan Li; Hui Xu; Ruijie Wang; Dengzhou Chen; Ming Fang; Tao Liu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

5.  Risk Factors for SARS-CoV-2 Infection, Pneumonia, Intubation, and Death in Northeast Mexico.

Authors:  Hid Felizardo Cordero-Franco; Laura Hermila De La Garza-Salinas; Salvador Gomez-Garcia; Jorge E Moreno-Cuevas; Javier Vargas-Villarreal; Francisco González-Salazar
Journal:  Front Public Health       Date:  2021-07-05

6.  A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.

Authors:  Limin Yang; Deyu Tian; Jian-Bao Han; Wenhui Fan; Yuan Zhang; Yunlong Li; Wenqiang Sun; Yanqiu Wei; Xiaodong Tian; Dan-Dan Yu; Xiao-Li Feng; Gong Cheng; Yuhai Bi; Yong-Tang Zheng; Wenjun Liu
Journal:  Innovation (N Y)       Date:  2021-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.